Virios Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
2.830
-1.045 (-26.97%)
At close: Oct 9, 2024, 4:00 PM
2.570
-0.260 (-9.19%)
Pre-market: Oct 10, 2024, 5:10 AM EDT
Virios Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Oct '24 Oct 9, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 4 | 11 | 4 | 43 | 59 | - | |
| Market Cap Growth | -76.41% | 155.97% | -89.85% | -27.56% | - | - | |
| Enterprise Value | 1 | 6 | -5 | 23 | 63 | - | |
| Last Close Price | 2.83 | 14.38 | 5.90 | 127.88 | 187.75 | - | |
| Debt / Equity Ratio | - | - | - | - | - | -0.74 | |
| Debt / FCF Ratio | - | - | - | - | - | -1.74 | |
| Quick Ratio | 6.04 | 9.25 | 6.74 | 10.98 | 19.45 | 0.19 | |
| Current Ratio | 7.27 | 11.62 | 8.02 | 12.37 | 20.55 | 0.19 | |
| Return on Equity (ROE) | -119.56% | -95.14% | -112.22% | -71.83% | -82.78% | - | |
| Return on Assets (ROA) | -67.76% | -54.32% | -63.75% | -41.38% | -39.34% | -713.17% | |
| Return on Capital (ROIC) | -76.59% | -61.16% | -70.53% | -43.99% | -43.67% | - | |
| Buyback Yield / Dilution | -25.11% | -69.62% | -32.91% | -69.06% | -1.95% | - | |
| Total Shareholder Return | -25.11% | -69.62% | -32.91% | -69.06% | -1.95% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.